Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riccardi

Showing results (561-570 of 3,399) with videos related to

Pageof 340
Sort By:
Talanta|September 24, 2013
Development of a method for the analysis of underivatized amino acids by liquid chromatography/tandem mass spectrometry: application on Standard Reference Material 1649a (urban dust)Francesca Buiarelli, Valentina Gallo, Patrizia Di Filippo, et al.
Microorganisms|February 27, 2026
Tuberculosis Stewardship: Reducing Diagnostic Delay Across the Clinical Spectrum in Low-Incidence SettingsSara Benevento, Niccolò Riccardi, Giovanni Fumagalli, et al.
Chemical Research in Toxicology|January 10, 2017
Virtual Cross-Linking of the Active Nemorubicin Metabolite PNU-159682 to Double-Stranded DNAMatteo Scalabrin, Luigi Quintieri, Manlio Palumbo, et al.
International Journal of Cancer|December 1, 1981
Suppression of natural killer (NK) activity by splenic adherent cells of low NK-reactive miceC Riccardi, A Santoni, T Barlozzari, et al.
Bioorganic & Medicinal Chemistry|November 17, 2012
The interaction of nemorubicin metabolite PNU-159682 with DNA fragments d(CGTACG)(2), d(CGATCG)(2) and d(CGCGCG)(2) shows a strong but reversible binding to G:C base pairsStefania Mazzini, Leonardo Scaglioni, Rosanna Mondelli, et al.
International Journal of Molecular Sciences|April 17, 2025
Unlocking the Complexity of Antibody-Drug Conjugates: A Cutting-Edge LC-HRMS Approach to Refine Drug-to-Antibody Ratio Measurements with Highly Reactive PayloadsAndrea Di Ianni, Kyra J Cowan, Federico Riccardi Sirtori, et al.
Haematologica|February 24, 2001
Immune tolerance by intermittent factor VIII boluses in two high responder hemophilia A patientsR Landolfi, R de Cristofaro, I Lazzareschi, et al.
Pflugers Archiv : European Journal of Physiology|June 2, 2009
Novel regulatory aspects of the extracellular Ca2+-sensing receptor, CaRDaniela Riccardi, Brenda A Finney, William J Wilkinson, et al.
American Journal of Surgery|August 27, 2021
Platelet dysfunction in patients with traumatic intracranial hemorrhage: Do desmopressin and platelet therapy help or harm?Nina E Glass, Julia Riccardi, Helen Horng, et al.
The American Journal of Medicine|July 25, 1988
Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patientsP Jones, G P Bodey, K Rolston, et al.
Pageof 340

Showing results (561-570 of 3,399) with videos related to

Sort By:
Pageof 340
Talanta|September 24, 2013
Development of a method for the analysis of underivatized amino acids by liquid chromatography/tandem mass spectrometry: application on Standard Reference Material 1649a (urban dust)Francesca Buiarelli, Valentina Gallo, Patrizia Di Filippo, et al.
Microorganisms|February 27, 2026
Tuberculosis Stewardship: Reducing Diagnostic Delay Across the Clinical Spectrum in Low-Incidence SettingsSara Benevento, Niccolò Riccardi, Giovanni Fumagalli, et al.
Chemical Research in Toxicology|January 10, 2017
Virtual Cross-Linking of the Active Nemorubicin Metabolite PNU-159682 to Double-Stranded DNAMatteo Scalabrin, Luigi Quintieri, Manlio Palumbo, et al.
International Journal of Cancer|December 1, 1981
Suppression of natural killer (NK) activity by splenic adherent cells of low NK-reactive miceC Riccardi, A Santoni, T Barlozzari, et al.
Bioorganic & Medicinal Chemistry|November 17, 2012
The interaction of nemorubicin metabolite PNU-159682 with DNA fragments d(CGTACG)(2), d(CGATCG)(2) and d(CGCGCG)(2) shows a strong but reversible binding to G:C base pairsStefania Mazzini, Leonardo Scaglioni, Rosanna Mondelli, et al.
International Journal of Molecular Sciences|April 17, 2025
Unlocking the Complexity of Antibody-Drug Conjugates: A Cutting-Edge LC-HRMS Approach to Refine Drug-to-Antibody Ratio Measurements with Highly Reactive PayloadsAndrea Di Ianni, Kyra J Cowan, Federico Riccardi Sirtori, et al.
Haematologica|February 24, 2001
Immune tolerance by intermittent factor VIII boluses in two high responder hemophilia A patientsR Landolfi, R de Cristofaro, I Lazzareschi, et al.
Pflugers Archiv : European Journal of Physiology|June 2, 2009
Novel regulatory aspects of the extracellular Ca2+-sensing receptor, CaRDaniela Riccardi, Brenda A Finney, William J Wilkinson, et al.
American Journal of Surgery|August 27, 2021
Platelet dysfunction in patients with traumatic intracranial hemorrhage: Do desmopressin and platelet therapy help or harm?Nina E Glass, Julia Riccardi, Helen Horng, et al.
The American Journal of Medicine|July 25, 1988
Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patientsP Jones, G P Bodey, K Rolston, et al.
Pageof 340